Monoclonal Antibodies

Entity type image
Type: Keyphrase
Name: Monoclonal Antibodies
First reported May 24 2013 - Updated 10 hours ago - 1 reports

New Asthma Drug Could Treat Exacerbations

A fully human monoclonal antibody called dupilumab, being developed by Regeneron and Sanofi, thwarts activation of the Th2 immune response implicated in asthma by blocking two cytokines, interleukin-4 and interleukin-13, according to research published ... [Published RT Magazine - May 24 2013]
Entities: Asthma, Drugs, interleukin-4
First reported 22 hours ago - Updated 22 hours ago - 1 reports
National Cheng Kung University
National Cheng Kung University

Study Results from National Cheng Kung University in the Area of Pharmaceutical and Biomedical Analysis Reported

(NewsRx) -- By a News Reporter-Staff News Editor at Proteomics Weekly -- Data detailed on Pharmaceutical and Biomedical Analysis have been presented. According to news reporting originating in Tainan, Taiwan, by NewsRx journalists, research stated, "Liquid ... [Published NewsRX - 22 hours ago]
First reported May 24 2013 - Updated May 24 2013 - 1 reports
Brandeis University
Brandeis University

Agency Reviews Patent Application Approval Request for "Methods for the Development of Vaccines Based on Oligosaccharide-Oligonucleotide Conjugates"

(NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Brandeis University has been issued patent application serial number 701849, according to news reporting originating out of Washington, D.C., by NewsRx editors.The patent's inventors are ... [Published NewsRX - May 24 2013]
First reported May 24 2013 - Updated May 24 2013 - 1 reports

Different Types Of Pharmaceuticals

Tags: types of pharmaceuticals, pharmaceuticals, biomedical research, protein, biotech services, biotech company, biotech, science, health, businessAuthor RSS FeedIf you go to a drugstore, you would surely find out that there are many types of drugs that ... [Published Article Motron - May 24 2013]
First reported May 24 2013 - Updated May 24 2013 - 1 reports

New Immunotherapy Study Findings Have Been Reported from M.F. Bachmann et al

(NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators discuss new findings in Biotechnology. According to news reporting originating in Paris, France, by NewsRx journalists, research stated, "With the effective control ... [Published NewsRX - May 24 2013]
First reported May 24 2013 - Updated May 24 2013 - 1 reports

Research and Markets Adds Report: 2013 Clostridium Diagnostics Market

Research and Markets has announced the addition of the "2013 Clostridium Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country" report to its offerings. In a release, Research and Markets noted that report highlights incl ... [Published Individual.com - May 24 2013]
First reported May 24 2013 - Updated May 24 2013 - 1 reports

Cancer Monoclonal Antibody Partnering Terms and Agreements - 2013 Report Covers Over 1,000 Cancer Monoclonal Antibody Deals

(NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Research and Markets has announced the addition of the "Cancer Monoclonal Antibody Partnering Terms and Agreements" report to their offering.The Cancer Monoclonal Antibody Partnering ... [Published NewsRX - May 24 2013]
First reported May 24 2013 - Updated May 24 2013 - 1 reports

CMC Biologics and RuiYi Enter into an Agreement for Development of a Novel Anti-IL-6 Monoclonal Antibody

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- CMC Biologics announced the execution of an agreement with RuiYi Inc. to develop a cell line for RYI-008, a novel anti-IL-6 monoclonal antibody. CMC Biologics' proprietary CHEF1® ... [Published NewsRX - May 24 2013]
First reported May 21 2013 - Updated May 22 2013 - 3 reports

ElsaLys Biotech Reports First Round of Financing with Transgene and Sofimac Partners

ElsaLys Biotech, which specializes in the development of therapeutic monoclonal antibodies, announced a first round of financing of 2.1MEUR from the biopharmaceutical company Transgene and the investment fund Sofimac Partners. According to a release, ... [Published Individual.com - May 22 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Monoclonal Antibody Dupilumab Safe And Effective In Asthma Phase IIa Trial

A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to researchers. The randomized, double-blind, placebo-controlled trial tested the efficacy ... [Published Scientific Blogging - Medicine - May 21 2013]
First reported May 21 2013 - Updated May 21 2013 - 3 reports

Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Asthma Drug Seen as Potential Game Changer

/PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and (NASDAQ: REGN) today announced that the New England Journal of Medicine published online the positive Phase 2a study results of dupilumab (SAR231893/REGN668) in patients with moderate-to-severe ... [Published BioSpace - May 21 2013]
First reported May 20 2013 - Updated May 20 2013 - 2 reports

Apple Explores OLED For Its Smartwatch and 2 Other Hot Stocks to Watch

Apple ( NASDAQ:AAPL ): Current price $442.52Apple is said to be  testing 1.5-inch OLED displays for its smartwatch, according to Dylan Love at Business Insider,  from MacRumors. OLED constitutes the same display tech that is employed in higher-end televisions ... [Published Wall St. Cheat Sheet - May 20 2013]

Quotes

...According to news reporting originating in Tainan, Taiwan, by NewsRx journalists, research stated, "Liquid chromatography-tandem mass spectrometry-based proteomics for peptide mapping and sequencing was used to characterize the marketed monoclonal antibody trastuzumab and compare it with two biosimilar products, mAb A containing D359E and L361M variations at the Fc site and mAb B without variants. Complete sequence coverage (100%) including disulfide linkages, glycosylations and other commonly occurring modifications... We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3."
Study Results from National Cheng Kung University in the Area of Pharmaceutical and Biomedical An ... [Published NewsRX - 22 hours ago]
"Intriguingly, dupilumab showed substantial efficacy in objective and patient-reported endpoints when added to ICS and LABA and when those therapies were discontinued" said lead author Sally Wenzel, MD, director of the University of Pittsburgh Asthma Institute
New Asthma Drug Could Treat Exacerbations [Published RT Magazine - May 24 2013]
From the background information supplied by the inventors, news correspondents obtained the following quote: "Certain monoclonal antibodies have therapeutic... We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3."
Agency Reviews Patent Application Approval Request for "Methods for the Development of Vaccines B ... [Published NewsRX - May 24 2013]
According to the news reporters, the research concluded: "Further investigation is needed to explore the effects of long-term anti-VEGF therapy beyond 2 years."
Data from Johns Hopkins University Provide New Insights into Age-Related Macular Degeneration [Published NewsRX - May 24 2013]

More Content

All (1507) | News (1246) | Reports (37) | Blogs (85) | Audio/Video (0) | Fact Sheets (12) | Press Releases (127)
sort by: Date | Relevance
Ketamine Cousin Rapidly Lifts Depression Withou... [Published NIMH - 6 hours ago]
Study Results from National Cheng Kung Universi... [Published NewsRX - 22 hours ago]
Different Types Of Pharmaceuticals [Published Article Motron - May 24 2013]
PBS 500 Air-Wheel Bioreactor [Published Bioresearch Online - May 24 2013]
Deals Of The Week Ponders When $2.1 Billion Is ... [Published The IN VIVO Blog - May 24 2013]
New Asthma Drug Could Treat Exacerbations [Published RT Magazine - May 24 2013]
Agency Reviews Patent Application Approval Requ... [Published NewsRX - May 24 2013]
Roadmap for Commercialising Stem-Cell Based The... [Published Terrapinn - May 24 2013]
Pichia pastoris-Expressed Dengue 2 Envelope For... [Published Elites TV - May 24 2013]
East Coast Life Sciences Roundup: Regeneron, Ac... [Published Xconomy - May 24 2013]
Data from Johns Hopkins University Provide New ... [Published NewsRX - May 24 2013]
New osteoporosis drug combination outperforms c... [Published NewsRX - May 24 2013]
Treatment with 2 osteoporosis drugs better at i... [Published NewsRX - May 24 2013]
Biotech Stock Mailbag: Amarin, MannKind, Palatin [Published TheStreet.com - May 24 2013]
Northwest Biotherapeutics, Inc.: New Northwest ... [Published TransWorldNews - May 24 2013]
New Immunotherapy Study Findings Have Been Repo... [Published NewsRX - May 24 2013]
Pfizer Discontinues Late-Stage Trial of Inotuzu... [Published OncLive - May 24 2013]
New Drug May Change Treatment Of Asthma [Published Forbes.com - May 24 2013]
Research and Markets Adds Report: 2013 Clostrid... [Published Individual.com - May 24 2013]
Health and Medicine: New Health and Medicine Fi... [Published NewsRX - May 24 2013]
[ElsaLys Biotech] spins out of [Transgene], rai... [Published BioPortfolio - May 24 2013]
Peregrine Pharmaceuticals The Little Biotech Wi... [Published BioPortfolio - May 24 2013]
Wilex AG: New Wilex AG company profile published [Published TransWorldNews - May 24 2013]
Cancer Monoclonal Antibody Partnering Terms and... [Published NewsRX - May 24 2013]
Merrimack Pharmaceuticals Completes Enrollment ... [Published PipelineReview - May 24 2013]
CMC Biologics and RuiYi Enter into an Agreement... [Published NewsRX - May 24 2013]
High-Transmission Precision Optics: An Intervie... [Published AZoOptics - May 24 2013]
New Market Report Now Available: Crucell N.V. -... [Published Live-PR.com - May 23 2013]
Peregrine Pharmaceuticals, The Little Biotech W... [Published Seeking Alpha - May 23 2013]
Arsanis, Inc. Nominates Preclinical Candidate f... [Published BioSpace - May 23 2013]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
Kiran Mazumdar-Shaw, Peter Garcia, Hilary Koprowski, [more]
  •  
BioPortfolio Ltd, CMC Biologics, Alethia Biotherapeutics Inc, [more]
  •  
FDA Food & Drug Administration, American Brain Tumor Association, European Organization for Rare Diseases, [more]
  •  
Antibody, Cancer, Breast Cancer, [more]
  •  
Herceptin, Bavituximab, Abiraterone, [more]
  •  
Dublin, Lyon (France), Mumbai, [more]
  •  
United Kingdom, United States, China, [more]
  •  
Medicine, Biotechnology, Biology, [more]
  •  
Pharma & Biotech, Health, Banking & Financial Services, [more]
BioPortfolio, PharmaBiz, Business Wire Health News, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Deals Of The Week Ponders When $2.1 Billion Is ... [Published The IN VIVO Blog - May 24 2013]
With the oncology high season upon us and just about everyone in the industry scrambling to decode the secrets hidden in ASCO’s abstracts, we couldn’t help but stop and reflect on how at least one company got where it is in oncology today through stellar ...
Monoclonal Antibody Dupilumab Safe And Effectiv... [Published Scientific Blogging - Medicine - May 21 2013]
A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to researchers. The randomized, double-blind, placebo-controlled trial tested the efficacy ...
Apple Explores OLED For Its Smartwatch and 2 Ot... [Published Wall St. Cheat Sheet - May 20 2013]
Apple ( NASDAQ:AAPL ): Current price $442.52Apple is said to be  testing 1.5-inch OLED displays for its smartwatch, according to Dylan Love at Business Insider,  from MacRumors. OLED constitutes the same display tech that is employed in higher-end televisions ...
Apple Explores OLED For Its Smartwatch and 2 Ot... [Published Wall St. Cheat Sheet - May 20 2013]
Apple ( NASDAQ:AAPL ): Current price $442.52 Apple is said to be  testing 1.5-inch OLED displays for its smartwatch, according to Dylan Love at Business Insider, from MacRumors. OLED constitutes the same display tech that is employed in higher-end ...
Will ASCO Unlock Big Value in This Cancer Drug ... [Published EquityJungle - v0.1 - May 18 2013]
Filed under: Investing There's little denying that Roche 's cancer wonder drug Avastin has been a godsend to cancer patients and investors alike. Avastin -- which the Food and Drug Administration has approved to treat metastatic colorectal cancer ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
BioFront Technologies Receives Funding Through ... [Published EON: Enhanced Online News - May 23 2013]
Merrimack Pharmaceuticals Completes Enrollment ... [Published GlobeNewswire: Advertising News - May 23 2013]
Arsanis Nominates Preclinical Candidate for Sta... [Published EON: Enhanced Online News - May 23 2013]
Arsanis Nominates Preclinical Candidate for Sta... [Published Business Wire Science: Science News - May 23 2013]
Arsanis Nominates Preclinical Candidate for Sta... [Published Business Wire Health News - May 23 2013]
1 2 3 4 5 6 7 8 9 10 ...
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.